Accelovance: CRO merger creates global firm with services across drug life cycle
Accelovance and Linical are merging to create a contract research organization CRO with a global footprint in response to the need for largescale multinational clinical trials.
Read full article »
Accelovance is a provider of digital contract research solutions for pharmaceutical, biotechnology and medical device companies.
Read more